Tag: originator biologic
Biosimilar Switching: What Happens When You Change from Originator Biologic
Switching from an originator biologic to a biosimilar is safe for most patients with stable autoimmune conditions. Learn what really happens during the switch, why some people stop treatment, and how to make the transition work for you.
view morerecent posts
The FDA issues warning letters to manufacturers who violate safety and labeling laws. These letters are the first step in enforcement that can lead to recalls, fines, or criminal charges. Learn how the agency targets non-compliant companies and what you must do to avoid serious consequences.
Published ON: 1 DecChronic Alcohol Use Disorder affects millions and carries serious health risks-from liver damage to cancer and brain changes. Effective treatments exist, including medications, therapy, and support groups. Recovery is possible with the right help.
Published ON: 1 DecLithium carbonate generics require strict serum level monitoring due to their narrow therapeutic index. Learn how brand switches, dosing, age, and kidney function affect safety and effectiveness in bipolar disorder treatment.
Published ON: 12 DecCommunity health presentations are helping patients understand that generic drugs are just as safe and effective as brand-name medications-saving billions and improving adherence. Learn how public education is breaking down myths and expanding access.
Published ON: 1 DecHealthcare shortages are worsening across U.S. hospitals and clinics, with nurse staffing levels at critical lows. Patient safety, access to care, and provider burnout are all under severe strain - here’s what’s really happening on the ground.
Published ON: 15 Dec